Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-23-040625

Chief Financial Officer bought 5,000 shares at $1.41 ($7,050)

From the SEC's structured data for this filing

Trades in this filing

Gerber Brianna · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-01 Purchase : show line 1 in the form +5,000 $1.41 $7,050 27,436 D
Open-market purchases · 5,000 sh · avg $1.41 · $7,050
Loading xslF345X05/wk-form4_1701724341.xml…